Unum’s Long‑Term Care Reinsurance Deal Could Be A Game Changer For Unum Group (UNM)
Unum Group UNM | 0.00 |
- In early July 2026, Unum Group announced that its Unum Life Insurance Company of America subsidiary agreed to cede approximately US$3.80 billion of statutory reserves tied to around 50,000 individual long-term care policies to Fortitude Reinsurance Company Ltd. on a coinsurance basis, while Unum retains policy administration.
- This long-term care reinsurance deal marks a further step in shrinking Unum’s closed block exposure and aims to keep capital levels strong while limiting the impact on operating earnings mainly to reduced investment income and added financing costs.
- We’ll now explore how this long-term care reinsurance move, which reshapes Unum’s risk profile, interacts with the company’s broader investment narrative.
The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 16 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
Unum Group Investment Narrative Recap
To own Unum, you need to be comfortable with a primarily group benefits business that throws off steady cash while managing legacy long term care exposure. The Fortitude Re coinsurance deal furthers that de risking effort, and management expects only a modest near term earnings effect, so the key near term catalyst remains execution on capital deployment, while the largest ongoing risk is still adverse experience in the remaining long term care and group lines.
The recent dividend declaration of US$0.505 per share, following earlier increases and sizable buybacks, sits alongside this reinsurance move as part of the same capital story, showing how balance sheet flexibility and shareholder returns are being managed together with long term care risk transfer and core business investment.
Yet investors should still pay close attention to how any future long term care reserve strain could...
Unum Group’s narrative projects $13.3 billion revenue and $1.5 billion earnings by 2029. This implies revenue remaining fairly flat each year and a roughly $700 million increase in earnings from $781.4 million today.
Uncover how Unum Group's forecasts yield a $100.08 fair value, a 13% upside to its current price.
Exploring Other Perspectives
Three Simply Wall St Community fair value estimates for Unum span roughly US$100 to US$170 per share, showing how widely opinions can differ. Against that backdrop, the long term care reinsurance program and its impact on earnings volatility and capital strength are key themes you may want to compare across these different views.
Explore 3 other fair value estimates on Unum Group - why the stock might be worth as much as 92% more than the current price!
Decide For Yourself
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
- A great starting point for your Unum Group research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
- Our free Unum Group research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Unum Group's overall financial health at a glance.
Contemplating Other Strategies?
These stocks are moving-our analysis flagged them today. Act fast before the price catches up:
- Find 44 companies with promising cash flow potential yet trading below their fair value.
- Uncover the next big thing with 20 elite penny stocks that balance risk and reward.
- Invest in the nuclear renaissance through our list of 89 elite nuclear energy infrastructure plays powering the global AI revolution.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
